Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Jan-24 4:30 PM View:  | Giuffre Randall Michael Director | Diamedica Therapeutics Inc. (DMAC) | 02-Jan-24 | Grant | 19,196 | $2.80 | $53,748.80 | 5% 392.0K to 411.19K | |
| 02-Jan-24 4:47 PM View: | Pilnik Richard D. Director | Diamedica Therapeutics Inc. (DMAC) | 02-Jan-24 | Grant | 30,357 | $2.80 | $84,999.60 | 12% 248.25K to 278.6K | |
| 02-Jan-24 5:00 PM View: | Kuntz Richard Director | Diamedica Therapeutics Inc. (DMAC) | 02-Jan-24 | Grant | 14,285 | $2.80 | $39,998.00 | 100% 0 to 14.29K | |
| 02-Jan-24 5:05 PM View: | Semba Charles Pauling Director | Diamedica Therapeutics Inc. (DMAC) | 02-Jan-24 | Grant | 9,375 | $2.80 | $26,250.00 | 31% 29.94K to 39.32K | |
| 02-Jan-24 4:39 PM View: | Parsons James T. Director | Diamedica Therapeutics Inc. (DMAC) | 02-Jan-24 | Grant | 21,428 | $2.80 | $59,998.40 | 56% 38.51K to 59.94K | |
| 16-Nov-23 4:37 PM View: | Wambeke David J. Chief Business Officer | Diamedica Therapeutics Inc. (DMAC) | 16-Nov-23 | Private Purchase | 20,000 | $2.46 | $49,200.00 | 4% 507.11K to 527.11K | |
| 26-Jun-23 4:21 PM View: | Kellen Scott CFO and Secretary | Diamedica Therapeutics Inc. (DMAC) | 23-Jun-23 | Market Purchase | 10,000 | $3.91 | $39,100.00 | 45% 22.29K to 32.29K | (7%) |
| 26-Jun-23 4:42 PM View: | Giuffre Randall Michael Director | Diamedica Therapeutics Inc. (DMAC) | 23-Jun-23 | Gift | 15,000 | -- | -- | (4%) 407.0K to 392.0K | |
| 26-Jun-23 4:14 PM View: | Wambeke David J. Chief Business Officer | Diamedica Therapeutics Inc. (DMAC) | 23-Jun-23 | Market Purchase | 38,364 | $3.91 | $150,003.00 | 8% 468.75K to 507.11K | (7%) |
| 26-Jun-23 4:34 PM View: | Pauls Dietrich John President and CEO Director | Diamedica Therapeutics Inc. (DMAC) | 23-Jun-23 | Market Purchase | 12,787 | $3.91 | $49,997.20 | 23% 55.8K to 68.59K | (7%) |
| 26-Jun-23 4:42 PM View: | Giuffre Randall Michael Director | Diamedica Therapeutics Inc. (DMAC) | 23-Jun-23 | Market Purchase | 65,000 | $3.91 | $254,150.00 | 19% 342.0K to 407.0K | (7%) |
| 27-Jun-23 4:11 PM View: | von Koch Thomas 10% Owner | Diamedica Therapeutics Inc. (DMAC) | 23-Jun-23 | Market Purchase | 1,470,590 | $3.40 | $5,000,000.00 | 51% 2.86M to 4.33M | 6% |
| 26-Jun-23 4:03 PM View: | Pilnik Richard D. Director | Diamedica Therapeutics Inc. (DMAC) | 23-Jun-23 | Market Purchase | 38,363 | $3.91 | $149,999.00 | 18% 209.88K to 248.25K | (7%) |
| 26-Jun-23 4:26 PM View: | Semba Charles Pauling Director | Diamedica Therapeutics Inc. (DMAC) | 23-Jun-23 | Market Purchase | 12,787 | $3.91 | $49,997.20 | 75% 17.16K to 29.94K | (7%) |
| 11-Apr-23 5:40 PM View: | Wambeke David J. Chief Business Officer | Diamedica Therapeutics Inc. (DMAC) | 10-Apr-23 | Private Purchase | 468,750 | $1.60 | $750,000.00 | 100% 0 to 468.75K | |
| 03-Jan-23 4:19 PM View: | Pilnik Richard D. Director | Diamedica Therapeutics Inc. (DMAC) | 03-Jan-23 | Grant | 55,555 | $1.53 | $84,999.10 | 36% 154.33K to 209.88K | |
| 03-Jan-23 4:43 PM View: | Giuffre Randall Michael Director | Diamedica Therapeutics Inc. (DMAC) | 03-Jan-23 | Grant | 35,130 | $1.53 | $53,748.90 | 11% 306.87K to 342.0K | |
| 03-Jan-23 4:36 PM View: | Burroughs Amy L. Director | Diamedica Therapeutics Inc. (DMAC) | 03-Jan-23 | Grant | 17,156 | $1.53 | $26,248.70 | 31% 56.13K to 73.29K | |
| 03-Jan-23 4:25 PM View: | Semba Charles Pauling Director | Diamedica Therapeutics Inc. (DMAC) | 03-Jan-23 | Grant | 17,156 | $1.53 | $26,248.70 | 100% 0 to 17.16K | |
| 12-Dec-22 4:34 PM View: | Giuffre Randall Michael Director | Diamedica Therapeutics Inc. (DMAC) | 09-Dec-22 | Purchase | 37,079 | $1.43 | $53,023.00 | 14% 269.79K to 306.87K | |
| 12-Dec-22 4:34 PM View: | Giuffre Randall Michael Director | Diamedica Therapeutics Inc. (DMAC) | 08-Dec-22 | Private Purchase | 20,000 | $1.40 | $28,000.00 | 8% 249.79K to 269.79K | |
| 08-Dec-22 4:55 PM View: | Giuffre Randall Michael Director | Diamedica Therapeutics Inc. (DMAC) | 07-Dec-22 | Purchase | 22,574 | $1.40 | $31,603.60 | 10% 227.22K to 249.79K | |
| 08-Dec-22 4:55 PM View: | Giuffre Randall Michael Director | Diamedica Therapeutics Inc. (DMAC) | 06-Dec-22 | Private Purchase | 2,300 | $1.35 | $3,105.00 | 1% 224.91K to 227.22K | |
| 05-Dec-22 4:16 PM View: | Pilnik Richard D. Director | Diamedica Therapeutics Inc. (DMAC) | 05-Dec-22 | Private Purchase | 35,000 | $1.39 | $48,492.50 | 29% 119.33K to 154.33K | |
| 06-Dec-22 3:19 PM View: | von Koch Thomas 10% Owner | Diamedica Therapeutics Inc. (DMAC) | 02-Dec-22 | Private Purchase | 2,855,850 | $1.24 | $3,526,970.00 | 100% 2.86M to 5.71M | |
| 06-Dec-22 3:19 PM View: | von Koch Thomas 10% Owner | Diamedica Therapeutics Inc. (DMAC) | 02-Dec-22 | Sale | 2,855,850 | $1.24 | $3,526,970.00 | (50%) 5.71M to 2.86M | |
| 01-Dec-22 5:11 PM View: | Giuffre Randall Michael Director | Diamedica Therapeutics Inc. (DMAC) | 01-Dec-22 | Purchase | 46,133 | $1.20 | $55,359.60 | 20% 232.15K to 278.28K | |
| 05-Dec-22 4:08 PM View: | Giuffre Randall Michael Director | Diamedica Therapeutics Inc. (DMAC) | 01-Dec-22 | Private Purchase | 819 | $1.19 | $974.61 | < 1% 224.1K to 224.91K | |
| 01-Dec-22 5:11 PM View: | Giuffre Randall Michael Director | Diamedica Therapeutics Inc. (DMAC) | 30-Nov-22 | Purchase | 2,970 | $1.19 | $3,534.30 | 1% 229.18K to 232.15K | |
| 01-Dec-22 5:11 PM View: | Giuffre Randall Michael Director | Diamedica Therapeutics Inc. (DMAC) | 29-Nov-22 | Private Purchase | 18,125 | $1.19 | $21,568.80 | 9% 211.05K to 229.18K | |
| 16-Nov-22 8:56 PM View: | Pauls Dietrich John President and CEO Director | Diamedica Therapeutics Inc. (DMAC) | 16-Nov-22 | Private Purchase | 20,000 | $1.21 | $24,200.00 | 56% 35.8K to 55.8K | |
| 21-Jul-22 1:06 PM View: | von Koch Thomas 10% Owner | Diamedica Therapeutics Inc. (DMAC) | 08-Jul-22 | Private Purchase | 207,974 | $1.33 | $275,898.00 | 8% 2.65M to 2.86M | |
| 03-Jan-22 4:26 PM View: | Pilnik Richard D. Director | Diamedica Therapeutics Inc. (DMAC) | 03-Jan-22 | Grant | 23,762 | $3.58 | $85,068.00 | 25% 95.56K to 119.33K | |
| 03-Jan-22 4:21 PM View: | Parsons James T. Director | Diamedica Therapeutics Inc. (DMAC) | 03-Jan-22 | Grant | 16,773 | $3.58 | $60,047.30 | 77% 21.74K to 38.51K | |
| 03-Jan-22 4:09 PM View: | Giuffre Randall Michael Director | Diamedica Therapeutics Inc. (DMAC) | 03-Jan-22 | Grant | 15,026 | $3.58 | $53,793.10 | 8% 196.03K to 211.05K | 4% |
| 03-Jan-22 4:39 PM View: | Burroughs Amy L. Director | Diamedica Therapeutics Inc. (DMAC) | 03-Jan-22 | Grant | 11,182 | $3.58 | $40,031.60 | 25% 44.95K to 56.13K | |
| 15-Sep-21 10:00 PM View: | Alcorn Harry W Jr SVP, Clinical Operations | Diamedica Therapeutics Inc. (DMAC) | 15-Sep-21 | Market Purchase | 15,000 | $3.80 | $56,959.50 | 52% 28.98K to 43.98K | (4%) |
| 17-Aug-21 4:11 PM View: | Burroughs Amy L. Director | Diamedica Therapeutics Inc. (DMAC) | 16-Aug-21 | Market Purchase | 44,950 | $3.15 | $141,592.00 | 100% 0 to 44.95K | 4% |
| 16-Aug-21 4:27 PM View: | Alcorn Harry W Jr Senior VP, Clinical Operations | Diamedica Therapeutics Inc. (DMAC) | 16-Aug-21 | Market Purchase | 399 | $3.07 | $1,224.93 | 1% 28.58K to 28.98K | |
| 16-Aug-21 4:27 PM View: | Alcorn Harry W Jr Senior VP, Clinical Operations | Diamedica Therapeutics Inc. (DMAC) | 16-Aug-21 | Market Purchase | 20,322 | $3.09 | $62,828.90 | 246% 8.26K to 28.58K | |
| 17-Aug-21 10:00 PM View: | Pilnik Richard D. Director | Diamedica Therapeutics Inc. (DMAC) | 16-Aug-21 | Market Purchase | 15,000 | $3.27 | $49,064.00 | 19% 80.56K to 95.56K | 13% |
| 16-Aug-21 4:10 PM View: | Kellen Scott CFO and Secretary | Diamedica Therapeutics Inc. (DMAC) | 16-Aug-21 | Market Purchase | 10,000 | $3.15 | $31,463.00 | 81% 12.29K to 22.29K | (1%) |
| 04-Jan-21 4:12 PM View: | Pilnik Richard D. Director | Diamedica Therapeutics Inc. (DMAC) | 01-Jan-21 | Grant | 9,719 | $8.23 | $79,987.40 | 14% 70.85K to 80.56K | |
| 04-Jan-21 4:21 PM View: | Parsons James T. Director | Diamedica Therapeutics Inc. (DMAC) | 01-Jan-21 | Grant | 7,745 | $8.23 | $63,741.30 | 55% 14.2K to 21.95K | |
| 04-Jan-21 4:33 PM View: | Giuffre Randall Michael Director | Diamedica Therapeutics Inc. (DMAC) | 01-Jan-21 | Grant | 7,441 | $8.23 | $61,239.40 | 4% 189.01K to 196.45K | |
| 04-Dec-20 5:46 PM View: | Pilnik Richard D. Director | Diamedica Therapeutics Inc. (DMAC) | 04-Dec-20 | Market Purchase | 10,000 | $5.37 | $53,697.00 | 16% 60.85K to 70.85K | 69% |
| 23-Nov-20 4:22 PM View: | Giuffre Randall Michael Director | Diamedica Therapeutics Inc. (DMAC) | 20-Nov-20 | Market Purchase | 15,000 | $4.26 | $63,912.00 | 9% 174.01K to 189.01K | 113% |
| 10-Nov-20 8:16 AM View: | Kellen Scott CFO and Secretary | Diamedica Therapeutics Inc. (DMAC) | 09-Nov-20 | Market Purchase | 2,000 | $4.19 | $8,386.60 | 19% 10.29K to 12.29K | 117% |
| 02-Jun-20 4:33 PM View: | Pilnik Richard D. Director | Diamedica Therapeutics Inc. (DMAC) | 01-Jun-20 | Grant | 10,168 | $4.59 | $46,671.10 | 20% 50.68K to 60.85K | 98% |
| 02-Jun-20 4:49 PM View: | Parsons James T. Director | Diamedica Therapeutics Inc. (DMAC) | 01-Jun-20 | Grant | 8,102 | $4.59 | $37,188.20 | 133% 6.1K to 14.2K | 98% |
